The genetic basis of Lewy body dementia (LBD) is not well understood. Here, we performed
whole-genome sequencing in large cohorts of LBD cases and neurologically healthy …

Motivation The advent of long-read sequencing technologies has increased demand for the
visualization and interpretation of transcripts. However, tools that perform such visualizations …

Background There are currently no treatments that stop or slow the progression of Parkinson's
disease (PD). Case–control genome‐wide association studies have identified variants …

OBJECTIVES: To assess precision magnetic resonance imaging in the neonate and determine
whether there is an early maternal influence on the pattern of neonatal fat deposition in …

Importance Substantial genome-wide association study (GWAS) work in Parkinson disease (PD)
has led to the discovery of an increasing number of loci shown reliably to be associated …

OBJECTIVE Diet therapy in gestational diabetes mellitus (GDM) has focused on carbohydrate
restriction but is poorly substantiated. In this pilot randomized clinical trial, we challenged …

Recently, we reported oligoadenylate synthetase 1 (OAS1) contributed to the risk of Alzheimer’s
disease, by its enrichment in transcriptional networks expressed by microglia. However, …

Rapid-eye movement (REM) sleep behavior disorder (RBD), enactment of dreams during
REM sleep, is an early clinical symptom of alpha-synucleinopathies and defines a more …

OBJECTIVE: To examine associations between pregnancy physical activity and neonatal fat
mass and fat-free mass, birth weight, and small for gestational age (SGA). METHODS: We …

Mitochondrial dysfunction has been implicated in the etiology of monogenic Parkinson’s
disease (PD). Yet the role that mitochondrial processes play in the most common form of the …